Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts CRBU Hot Sheet
Join SI Premium – FREE
Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q2 EPS of ($0.35), $0.04 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.67 million versus the consensus estimate of $2.09 million.
For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Sony Semiconductor Solutions unveils 64MP mobile image sensor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
